External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort
- PMID: 31782886
- DOI: 10.1111/jth.14688
External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort
Abstract
Background: The simplified Geneva risk assessment model (RAM) predicts the risk of hospitalization-related venous thromboembolism (VTE) in medical inpatients in its developmental cohort but has not been validated.
Objectives: To externally validate the simplified Geneva RAM.
Patients/methods: For this secondary analysis of a prospective cohort set in Padua, we calculated the simplified Geneva RAM for all participants. They were followed up for 90 days for the occurrence of adjudicated VTE. Thirty- and 90-day risks of VTE were estimated by the Kaplan-Meier method, and categories of risks compared with a Cox regression model adjusted for the use of thromboprophylaxis.
Results: Among 1180 medical inpatients, the 90-day risk of symptomatic VTE was 3.1%. The simplified Geneva RAM classified 56.9% as high risk (≥3 points; 90-day risk of VTE of 5.2%) and 43.1% as low risk (<3 points; 90-day risk of VTE of 0.4%). Compared with low-risk participants, high-risk participants had an 18-fold greater risk of VTE than low-risk participants (hazard ratio [HR] 17.9, 95% confidence interval [CI] 4.3-74.7). A very high-risk category (≥7 points) identified 5.3% of participants with a 9.5% probability of VTE at 90 days.
Conclusions: In this external validation study, we confirm the excellent discrimination and clinically adequate calibration of the simplified Geneva RAM as a stratification tool to guide the use of thromboprophylaxis.
Keywords: decision support techniques; hospitalization; pulmonary embolism; risk assessment; venous thrombosis.
© 2019 International Society on Thrombosis and Haemostasis.
Similar articles
-
Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort.Res Pract Thromb Haemost. 2020 Nov 6;5(1):142-147. doi: 10.1002/rth2.12361. eCollection 2021 Jan. Res Pract Thromb Haemost. 2020. PMID: 33537538 Free PMC article.
-
Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review.BMJ Open. 2021 Jul 29;11(7):e045672. doi: 10.1136/bmjopen-2020-045672. BMJ Open. 2021. PMID: 34326045 Free PMC article.
-
Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients.Thromb Haemost. 2018 Jan;118(1):82-89. doi: 10.1160/TH17-06-0403. Epub 2018 Jan 5. Thromb Haemost. 2018. PMID: 29304528
-
Risk Assessment Models for Venous Thromboembolism in Medical Inpatients.JAMA Netw Open. 2024 May 1;7(5):e249980. doi: 10.1001/jamanetworkopen.2024.9980. JAMA Netw Open. 2024. PMID: 38728035 Free PMC article.
-
Derivation and External Validation of a Risk Assessment Model of Venous Thromboembolism in Hospitalized Chinese Patients.Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296221151164. doi: 10.1177/10760296221151164. Clin Appl Thromb Hemost. 2023. PMID: 36650933 Free PMC article. Review.
Cited by
-
The Use of Risk Scores for Thromboprophylaxis in Medically Ill Patients-Rationale and Design of the RICO trial.TH Open. 2024 Jan 12;8(1):e55-e60. doi: 10.1055/a-2209-4708. eCollection 2024 Jan. TH Open. 2024. PMID: 38222040 Free PMC article.
-
Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort.Res Pract Thromb Haemost. 2020 Nov 6;5(1):142-147. doi: 10.1002/rth2.12361. eCollection 2021 Jan. Res Pract Thromb Haemost. 2020. PMID: 33537538 Free PMC article.
-
Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study.BMJ Med. 2024 Feb 21;3(1):e000408. doi: 10.1136/bmjmed-2022-000408. eCollection 2024. BMJ Med. 2024. PMID: 38389721 Free PMC article.
-
Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis.Health Technol Assess. 2024 Apr;28(20):1-166. doi: 10.3310/AWTW6200. Health Technol Assess. 2024. PMID: 38634415 Free PMC article.
-
Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review.BMJ Open. 2021 Jul 29;11(7):e045672. doi: 10.1136/bmjopen-2020-045672. BMJ Open. 2021. PMID: 34326045 Free PMC article.
References
REFERENCES
-
- Blondon M, Limacher A, Righini M, Aujesky DA, Méan M. Adequacy of Hospital Thromboprophylaxis and Risk Assessment Models in the SWITCO65+ Cohort. Res Pract Thromb Haemost. 2019;3:760.
-
- Cobben MRR, Nemeth B, Lijfering WM, Cannegieter SC. Validation of risk assessment models for venous thrombosis in hospitalized medical patients. Res Pract Thromb Haemost John Wiley & Sons, Ltd. 2019;3:217-225.
-
- Blondon M, Spirk D, Kucher N, et al. Comparative performance of clinical risk assessment models for hospital-acquired venous thromboembolism in medical patients. Thromb Haemost Schattauer GmbH. 2018;118:82-89.
-
- Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8:2450-2457.
-
- Spyropoulos AC, Anderson FA, Fitzgerald G, et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011;140:706-714.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources